Teva’s (TEVA) $125 Million BioXcel Bid Offers Upside, but FDA and Auction Risks Remain
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Health & Medicine
Tory health critic livid after being rebuffed by health officials
The health critic for the Progressive Conservative party says her ability to get information about the accelerated reopening of Dauphin’s emergency department was stymied by Prairie Mountain Health…
DR Congo Ebola outbreak crosses 7,000 cases
The Democratic Republic of Congo has recorded more than 7,000 Ebola cases in its worst outbreak of the disease. Congolese authorities reported 7,022 cases since the epidemic began.
Loss of legal immigrant caregivers puts America's seniors at risk
Every lapsed visa or expired protection is a resident who loses the person who knows their routines, care needs and potential risks best.
Childhood Cancer Canada calls for $15M from feds as demand rises
Childhood Cancer Canada says demand for its financial support programs has risen 40 per cent in two years as families face the long-term costs of a diagnosis.
Childhood Cancer Canada calls for $15M from feds as demand rises
Childhood Cancer Canada says demand for its financial support programs has risen 40 per cent in two years as families face the long-term costs of a diagnosis.